Prevalence of ESBL Escherichia coli in urinary tract infections
Wanda C. Reygaert
Rotavirus vaccine trials in bangladesh: Findings and lessons learned from phase I to IV studies
K Zaman
Antimicrobial resistance surveillance for nosocomial pathogens
Olga Perovic
Molecular studies on drug resistant malaria in India
Y.D. Sharma
Antimicrobial resistance among nosocomial isolates in a public hospital in Peru
Yuri Garcia Cortez, Raul Montalvo, Ruben Dario Vasquez, Jaime Alvarezcano
Globalization of antimicrobial resistance: Challenges and response in developing world
Dave N G, Trivedi A V, Jani V R, Raval D A, Mevada M S and Dave S M
Computer aided docking studies of some antimicrobial agents
Jignasa K. Savjani and Anuradha K. Gajjar
Ahmed H. Salem, Ehab A. Noreddin, George G. Zhanel, Ayman M. Noreddin
Impediments to the rational design of a structure-based HIV-1 vaccine
Marc H.V. Van Regenmortel
Chinnaswamy Jagannath
Xiaohua Qian
Silvia Vendetti
Epitope based vaccine design against Japanese encephalitis virus.
Bhawna Rathi
Pallavi Somvanshi and B.N. Mishra
Protein- and DNA-based epitope vaccines for Alzheimer's disease
Michael G. Agadjanyan
Novel strategy for oral vaccine against pathogens
Mansour Mohamadzadeh
Quality control for malaria subunit vaccines
Daming Zhu
Hiroshi Kido, Dai Mizuno, Takashi Kimoto, Takuya Kunimi and Shinji Ono
Malaria vaccine development: The Plasmodium falciparum serine repeat antigen
Toshihiro Horii
Fabio T. M. Costa
Studies on the development of the ovaries of the malaria mosquitoes (Anopheles pharoensis)
Abeer S. Yamany
Studies on the development of the ovaries of the malaria mosquitoes (Anopheles pharoensis)
Abeer S. Yamany
Daesub Song, Jeongki Kim, Haryoung Poo, Hyoungjoon Moon and Bokyu Kang
Granulysin is a cytotoxic and proinfl ammatory effector molecule
Veronica E. Calderon, Ediane Silva, Lorena Santos, W. Ray Waters, Mitchell V Palmer, Tyler C. Thacker, William R. Jacobs Jr., Michelle H. Larsen, Catherine Vilcheze, and D. Mark Estes
Hepatitis A Vaccination in healthcare workers
Praveen Guturu, Luca Cicalese, and Andrea Duchini
Yutaka Kishida
MHC Class I TCR driven CD4+ antitumor T Cells for cancer immunotherapy.
Arvind Chhabra
Semiallogenic vaccines for the treatment of cancer and neurological disorders
Mark S. Kindy
Ara Hovanessian
Mimotopes selected with neutralizing antibody against multiple subtypes of infl uenza A
Yanwei Zhong, Jiong Cai, Chuanfu Zhang, Lu Liu, Dongqing Zhou, JiaqiHan, Shishu Zhu, Hongfei Zhang, Hongbin Song, Dongping Xu
Prevention of estrogenindependent breast cancer using her family targeted dendritic cell vaccines
Brian J Czern
Mark Malek, John Costumbrado, Garrett Cox, Armidia Miranda RN, A. Nelson El Amin and Ali Stirland
Pork industry intensifi cation and the changing ecology and epidemiology of swineorigin infl uenza
Michael Greger
Vaccination of lactating dairy cows for the prevention of afl atoxins carry over in the milk
Luciano Polonelli
Vorobiev D.S., Semenova I.B
Challenges in the development of vaccines for leptospirosis in the philippines
Nina G. Gloriani, Lolita L. Cavinta, Rubelia A. Baterna, Crystal Amiel Estrada, Anna Kriselda Rivera, Shin-ichi Yoshida, Sharon Y.A.M. Villanueva and Yasutake Yanagihara
Edda Sciutto
Guo Aizhen
Bacterial ghost: Novel approach of vaccine delivery in aquaculture
Sontakke U.B, Muneendra Kumar, S.K. Asraf Houssain, Sagar Jadhav, Patil C.S and Harjit Kaur
Production of tissue culture anti rabies vaccine for human use in Nepal
Ganesh Raj Pant
Laura Manna
Jimmy Kwang
Nisha Jain Garg, Shivali Gupta, and Juan Carlos Vazquez-Chagoyan
In situ immunization followed by adoptive cellular therapy against breast cancer
Masoud H Manjili
Carbohydrate based vaccines for the treatment of cancer
Livingston P.O and Ragupathi G
Therapeutic vaccines using immune regulatory functions of invariant natural killer T (iNKT) cells
Yasuyuki Ishi
Synthetic virus-like particles in vaccine design
Arin Ghasparian
Gl�ucia Paranhos-Baccal�
Vipin Kumar Deo, Yoshitaka Tsuji, Tomomi Yasuda, Tatsuya Kato, Naonori Sakamoto, Hisao Suzuki and Enoch Y Park
Sharad Mangal, Jaganathan KS, Raman Rao
Nanoparticle-mediated delivery of siRNA targeting the HIV-1 coreceptor CXCR4 in HeLa-derived cells
Carole Lavigne, Arnold J, Kell, Alain R. Thierry, Michael L. Barnes, Niranjala Gajanayaka, Kathryn Slater
Synthetic QS-21 and Rationally Designed QS- 21 Analogs
Jeffrey R Gardner
HZ incidence rates increase: Is this due to varicella vaccine use in children?
Barbara P. Yawn, Peter Wollan and Marge Kurland RN
The innate immune response to the plague vaccine in vaccination and protection
Kei Amemiya
Tailoring induction of CD8 T cell quantity and phenotype by vaccine adjuvants
Lakshmi Krishnan, Felicity C Stark, Valeria Alcon, Fanny Tzelepis, G. Dennis Sprott and Subash Sad
Protein transfer approach to cancer vaccine development
Periasamy Selvaraj
Fang-Ping Huang
Vaccine therapy for lymphomas: From bench to bedside and back
Sattva S. Neelapu
Huijun Lu, Lei Tan, Mingyao Tian and Ningyi Jin
Beka Solomon
Rebounding of dendritic cells post chemotherapy: Implication for cancer immunotherapy
Mohamed L. Salem
Pathogen-associated molecular patterns on biomaterials: A paradigm for engineering new vaccines
Tarek M. Fahmy
Identifi cation of immunogenic proteins and generation of antibodies by phage display
Andre Franzel and Michael Hust
Bokyu Kang
Chad Rittle
Edmund J. Gosselin, Constantine Bitsaktsis and Bibiana Iglesias
Chitosan-based particles as adjuvants for Hepatitis B needle-free vaccines?
Olga Borges
Colonisation endpoints in vaccine trials - design questions for Streptococcus pneumoniae
Kari Auranen
Sudipta Bhowmick and Nahid Ali
Role of immune modulator KMK as a vaccine adjuvant
Farah Khan
Novel vaccine candidates for an improved a cellular vaccine of B. pertussis
Mar�a Eugenia Rodriguez
Malaria vaccine related studies in Iran: Past, present and future
Saber Gholizadeh
Ana M. Espino and Fracheska Rivera
Non-infl ammatory adjuvant for cutaneous vaccination
Mei X. Wu, Xinyuan Chen and Richard R. Anderson
Mechanism of action of the oil in water emulsion vaccine adjuvant MF59
Ennio De Gregorio
Recent advances in high throughput screening methods for formulation development of vaccines
S. Fernando Ausar
R. Zichel, A. Mimran, E. Diamant, A. Keren, A. Barnea, I. Steinberger- Levy, D. Marcus, A. Turgeman, and S. Reuveny
Recent advances in high throughput screening methods for formulation development of vaccines
S. Fernando Ausar
R. Zichel, A. Mimran, E. Diamant, A. Keren, A. Barnea, I. Steinberger- Levy, D. Marcus, A. Turgeman, and S. Reuveny
Flavio Guimaraes da Fonseca, Lorena Falabella Daher de Freitas and B�rbara Resende Quinan
Lina Hu and Lei Yu
Haileleul Negussie, Gelagay Ayelet, Shiferaw JT and Esayas Gelaye
Antoine Danchin
Haileleul Negussie, Gelagay Ayelet, Shiferaw JT and Esayas Gelaye
Antoine Danchin
Henok Tadesse Ayele, Amare Deribew, Mirkuzie Woldie
Computational model for proliferation-able muscle stem cells
Obaidul Malek, Anastasios Venetsanopoulos, Thomas Hawke, Laila Alamgir, Sri Krishnan and Javad Alirezaie